Physiologically‐Based Pharmacokinetic Modeling for the Prediction of a Drug-Drug Interaction of Combined Effects on P‐glycoprotein and Cytochrome P450 3A
Direct oral anticoagulants, such as apixaban and rivaroxaban, are important for the treatment and prophylaxis of venous thromboembolism and to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Because apixaban and rivaroxaban are predominantly eliminat...
Saved in:
Main Authors: | Yukio Otsuka (Author), Mary P. Choules (Author), Peter L. Bonate (Author), Kanji Komatsu (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of genetic polymorphisms on the interplay of P-glycoprotein transporter and cytochrome P450 enzymes: Pharmacokinetics of risperidone
by: Yong-Bok Lee
Published: (2016) -
Effects of resveratrol on P-glycoprotein and cytochrome P450 3A in vitro and on pharmacokinetics of oral saquinavir in rats
by: Li JP, et al.
Published: (2016) -
Pharmacokinetic interaction of drugs, the metabolisable cytochrome P450 isoenzyme CYP2C9
by: O. G. Gribakina, et al.
Published: (2020) -
Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan In Vitro and In Vivo
by: Yiran Wang, et al.
Published: (2020) -
In Silico Prediction of Drug-Drug Interactions Mediated by Cytochrome P450 Isoforms
by: Alexander V. Dmitriev, et al.
Published: (2021)